Department of Medicine, Tufts Medical Center, Boston, Massachusetts.
Section of Geriatric Medicine, Division of Primary Care and Population Health, Stanford University, Stanford, California; Geriatric Research and Education Clinical Center, Palo Alto Veterans Affairs Health Care System, Palo Alto, California.
Am J Kidney Dis. 2023 Jan;81(1):59-66. doi: 10.1053/j.ajkd.2022.06.008. Epub 2022 Aug 6.
RATIONALE & OBJECTIVE: The safety and efficacy of long-term exercise training in reducing physical functional loss in older adults with advanced CKD and comorbidity is uncertain.
Multicenter, parallel group, randomized controlled trial.
SETTINGS & PARTICIPANTS: Adults 55 years and older with estimated glomerular filtration rate (eGFR) of 15 to <45 mL/min/1.73 m enrolled from centers in Baltimore and Boston.
Twelve months of in-center supervised exercise training incorporating majority aerobic but also muscle strengthening activities or a group health education control intervention, randomly assigned in 1:1 ratio.
Primary outcomes were cardiorespiratory fitness and submaximal gait at 6 and 12 months quantified by peak oxygen consumption (Vopeak) on graded exercise treadmill test and distance walked on the 6-minute walk test, respectively. Secondary outcomes were changes in lower extremity function, eGFR, albuminuria, glycemia, blood pressure, and body mass index.
Among 99 participants, the mean age was 68 years, 62% were African American, and the mean eGFR was 33 mL/min/1.73 m; 59% had diabetes, and 29% had coronary artery disease. Among those randomized to exercise, 59% of exercise sessions were attended in the initial 6 months. Exercise was well tolerated without excess occurrence of adverse events. At 6 months, aerobic capacity was higher among exercise participants (17.9 ± 5.5 vs 15.9 ± 7.0 mL/kg/min, P = 0.03), but the differences were not sustained at 12 months. The 6-minute walk distance improved more in the exercise group (adjusted difference: 98 feet [P = 0.02; P = 0.03 for treatment-by-time interaction]). The exercise group had greater improvements on the Timed Up and Go Test (P = 0.04) but not the Short Physical Performance Battery (P = 0.8).
Planned sample size was not reached. Loss to follow-up and dropout were greater than anticipated.
Among adults aged ≥55 years with CKD stages 3b-4 and a high level of medical comorbidity, a 12-month program of in-center aerobic and resistance exercise training was safe and associated with improvements in physical functioning.
Government grants (National Institutes of Health).
Registered at ClinicalTrials.gov with study number NCT01462097.
对于患有晚期 CKD 和合并症的老年人,长期运动训练在减少身体功能丧失方面的安全性和疗效尚不确定。
多中心、平行组、随机对照试验。
来自巴尔的摩和波士顿中心的年龄在 55 岁及以上、估计肾小球滤过率(eGFR)为 15 至<45 mL/min/1.73 m²的成年人参加。
12 个月的中心监督运动训练,包括主要的有氧运动,但也包括肌肉强化活动或团体健康教育对照干预,以 1:1 的比例随机分配。
主要结局是心肺适能和亚最大步态,分别通过分级运动跑步机测试的峰值摄氧量(Vopeak)和 6 分钟步行测试的步行距离来量化。次要结局是下肢功能、eGFR、白蛋白尿、血糖、血压和体重指数的变化。
在 99 名参与者中,平均年龄为 68 岁,62%为非裔美国人,平均 eGFR 为 33 mL/min/1.73 m²;59%患有糖尿病,29%患有冠状动脉疾病。在随机分配到运动组的患者中,59%的运动课程在最初的 6 个月内完成。运动耐受性良好,无不良事件发生。在 6 个月时,运动参与者的有氧能力更高(17.9 ± 5.5 与 15.9 ± 7.0 mL/kg/min,P=0.03),但 12 个月时没有持续。6 分钟步行距离在运动组中改善更多(调整差异:98 英尺[P=0.02;P=0.03 治疗与时间的交互作用])。运动组在 Timed Up and Go 测试中(P=0.04)有更大的改善,但在简短的体能电池测试中(P=0.8)没有改善。
计划的样本量未达到。随访和辍学的损失大于预期。
在患有 CKD 3b-4 期和高度合并症的 55 岁及以上成年人中,为期 12 个月的中心有氧和阻力运动训练计划是安全的,并与身体功能的改善相关。
政府拨款(美国国立卫生研究院)。
在 ClinicalTrials.gov 注册,注册号为 NCT01462097。